emoxypine succinate has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artamoshina, NE; Baĭder, LM; Belaia, OL; Kuropteva, ZV; Radzevich, AE | 1 |
| Baĭder, LM; Belaia, OL; Fomina, IG; Kuropteva, ZV | 1 |
| Cherednik, IL; Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Popov, PB; Sheĭkh-Zade, IuR; Sirotenko, DV; Turovaia, AIu; Uvarov, AV | 1 |
3 other study(ies) available for emoxypine succinate and Coronary Disease
| Article | Year |
|---|---|
[Correction of antioxidative state during statin therapy of coronary heart disease with dyslipidemia].
Topics: Antioxidants; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Picolines; Simvastatin; Treatment Outcome | 2009 |
[Effects of mexidol on the antioxidative status of patients suffering from coronary heart disease with dislipidemia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dyslipidemias; Humans; Lipid Peroxidation; Middle Aged; Nitrates; Picolines; Time Factors; Treatment Outcome | 2005 |
[Anti-arrhythmia activity of befol, sufan, mexidol, and T3-146 in combination with other anti-arrhythmia agents].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Benzamides; Cats; Coronary Disease; Drug Synergism; Morpholines; Myocardial Reperfusion Injury; Picolines; Piracetam; Succinates; Tryptophan | 1998 |